Nevro obtains FDA approval for AI-based spinal cord stimulation system
Medical device company Nevro has received approval from the US Food and Drug Administration (FDA) and announced a limited ...
Nevro Announces the Launch of HFX AdaptivAI™, the Only AI-Driven Technology in Spinal Cord Stimulation
Nevro Corp. (NYSE: NVRO), a global medical device company that is delivering comprehensive, life-changing solutions for the ...
Becker's Spine Review2d
Nevro launches AI-powered spinal cord stimulator
Nevro earned FDA approval and began a limited market release of its HFX iQ spinal cord stimulator with HFX AdaptivAI, the company said Sept. 24.
MassDevice2d
Nevro wins FDA nod for AI-driven spinal cord stimulation tech
Nevro announced today that it received FDA approval for an AI-powered, personalized pain management platform for spinal cord ...
Le Lézard2d
Nevro Announces the Launch of HFX AdaptivAItm, the Only AI-Driven Technology in Spinal Cord Stimulation
Nevro Corp. , a global medical device company that is delivering comprehensive, life-changing solutions for the treatment of ...
NeuroOne® Spinal Cord Stimulation Electrode Technology to be Featured at The Business of Pain Conference
Minimally invasive technology would allow for percutaneous placement of a paddle electrodeRenowned pain specialist Dr. Sean Li to present on this ...
Zacks.com on MSN1d
NVRO Stock May Gain on the FDA Approval of Its HFX AdaptivAI Platform
Nevro NVRO recently announced the FDA clearance and limited market release of HFX iQ with HFX AdaptivAI, a responsive, personalized pain management platform powering the HFX iQ spinal cord stimulation ...
Nature21d
The molecular basis of pain and its clinical implications in rheumatology
A form of pain hypersensitivity in which low-intensity stimulation that would normally ... The primary receptor for norepinephrine in the spinal cord is the α2 adrenergic receptor, which acts ...
BMJ22d
Effects of Testosterone and Evoked Resistance Exercise after Spinal Cord Injury (TEREX-SCI): study protocol for a randomised controlled trial
The trial will investigate the use of surface neuromuscular electrical stimulation-induced resistance training (NMES-RT) to restore muscle size after spinal cord injury (SCI ... A randomised ...
Science News1d
A study in mice hints at a new way to treat spinal cord injuries
A drug called bumetanide, which is used to treat edema in people, reduced this cellular swelling and resulting cell death in mice. Mice given the drug after an injury were better able to move their ...